The regulatory role of IRP2 in mitochondrial iron metabolism renders it a pivotal element in the resistance of cancer cells to treatments, such as chemotherapy and radiation, owing to its influence on pathways that might promote tumor growth and recurrence [8–10]. Here, IREB2 is linked to cancer.